TWIST1 and breast carcinoma: Indeed, similar to the previous studies conducted in clear-cell renal cell carcinoma and breast cancer cell lines [29, 30], HIF-1α binding to the HRE of the TWIST1 proximal promoter was also inhibited by CpG methylations of the element as demonstrated by EMSA (Fig. S5A).